Huang, Kang-Chieh
Gomes, Cátia
Shiga, Yukihiro
Belforte, Nicolas
VanderWall, Kirstin B.
Lavekar, Sailee S.
Fligor, Clarisse M.
Harkin, Jade
Hetzer, Shelby M.
Patil, Shruti V.
Di Polo, Adriana
Meyer, Jason S. https://orcid.org/0000-0001-9037-6033
Funding for this research was provided by:
National Eye Institute (R01EY033022, U24EY033269, R01EY030838)
BrightFocus Foundation (G2020369, G2022003F)
Glaucoma Research Foundation
Indiana State Department of Health (26343)
Fonds de Recherche du Québec - Santé (276181)
Canadian Institutes of Health Research (458569)
Gilbert Family Foundation (923016)
Article History
Received: 27 June 2024
Accepted: 6 October 2024
First Online: 18 October 2024
Declarations
:
: All experiments outlined within this manuscript were performed according to either IBC protocols.approved by Indiana University or animal use (IACUC) protocols approved by the University of Montreal.
: Not applicable.
: JSM holds a patent related to methods for the retinal differentiation of human pluripotent stem cells used in this study, and ADP holds a Canada Research Chair (Tier 1).